Detalles de la búsqueda
1.
A phase1 study of stereotactic gene delivery of AAV2-NGF for Alzheimer's disease.
Alzheimers Dement
; 10(5): 571-81, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-24411134
2.
Issues regarding gene therapy products for Parkinson's disease: the development of CERE-120 (AAV-NTN) as one reference point.
Parkinsonism Relat Disord
; 13 Suppl 3: S469-77, 2007.
Artículo
en Inglés
| MEDLINE | ID: mdl-18267286
3.
Advancing neurotrophic factors as treatments for age-related neurodegenerative diseases: developing and demonstrating "clinical proof-of-concept" for AAV-neurturin (CERE-120) in Parkinson's disease.
Neurobiol Aging
; 34(1): 35-61, 2013 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-22926166
Resultados
1 -
3
de 3
1
Próxima >
>>